Rapid advances in immuno-oncology (IO) over the last decade have seen the emergence of hundreds of new immunotherapy companies, with a wealth of investigational therapies and combination therapies entering the pipeline.

Exploratory and preclinical studies often require rapid development of assays to inform key development decisions.

Strong association with and high prevalence of the PNPLA3 I148M (rs738409) variant in the general population, and especially high prevalence in Hispanic and Asian populations, make it an ideal candidate as a therapeutic target as well as a potential diagnostic test to identify individuals at increased risk of progression to late-stage liver disease.

The Audacious Goals Initiative (AGI) for regenerative medicine is a program run by the National Eye Institute (NEI), aimed at finding new therapies for eye diseases that remain difficult to treat.

Incorporating an inhalation device in your drug development creates greater complexity in dose administration, enhancing the need for knowledge sharing and collaboration across drug development teams between nonclinical and first-in-human (FIH) studies.

A growing biotech company was researching early phase development of RNA-based therapies against cancer, a promising area of study that has shown potential to improve precision medicine with targeted therapy that weakens and slows the growth of harmful tumor cells.

A primary objective of the Labcorp inhalation studies group is to conduct all studies using the most efficient test article delivery methods available in order to contain and minimize the cost of preclinical product testing to our customers.

Early phase development programs involve many moving parts, and it's critical to keep on track. Program management makes it easy. By choosing program management, you'll receive end-to-end support that ensures your program gets the attention it needs across teams according to your milestones.

The fate of bees and other pollinators is of interest to businesses, regulators, the media and the general public due to concerns about declining colony numbers and increasing incidents of ill health amongst pollinators. The precise reasons for these unwelcome developments are complex and multi-factorial.